BioCorRx Inc. (BICX) financial statements (2023 and earlier)

Company profile

Business Address 2390 EAST ORANGEWOOD AVENUE
ANAHEIM, CA 92806
State of Incorp.
Fiscal Year End December 31
SIC 8093 - Specialty Outpatient Facilities, Not Elsewhere Classified (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments865922,6462801192220
Cash and cash equivalents865922,6462801192220
Restricted cash and investments    11  
Prepaid expense851572133113864
Other undisclosed current assets58225187819 28
Total current assets:2289753,04731955101312
Noncurrent Assets
Operating lease, right-of-use asset385490459
Property, plant and equipment1031291484419224
Long-term investments and receivables4545421313185
Long-term investments4545421313185
Intangible assets, net (including goodwill)111771415252  
Intangible assets, net (excluding goodwill)111771415252  
Prepaid expense      9
Other undisclosed noncurrent assets4813224236 3301,075
Total noncurrent assets:5928528873092843701,093
TOTAL ASSETS:8201,8273,9336283394701,405
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:3,1892,4902,0271,5551,2009381,257
Accounts payable1,7771,181709656715  
Accrued liabilities    1769223
Interest and dividends payable1,1541,1381,138898483  
Settlement liabilities    15315 
Other undisclosed accounts payable and accrued liabilities2581711800(189)5311,234
Deferred revenue3563135
Debt221 (55)673 1731,461
Derivative instruments and hedges, liabilities     295111
Due to related parties  3913277196106
Deferred revenue and credits237433636
Other undisclosed current liabilities941499533,868124417185
Total current liabilities:4,3863,0522,5516,1271,6382,4513,755
Noncurrent Liabilities
Long-term debt and lease obligation 435428    
Operating lease, liability 435428
Liabilities, other than long-term debt, including:37721032082,5936,150933
Deferred revenue and credits401613845
Deferred revenue3772103
Derivative instruments and hedges, liabilities     4,82060
Other undisclosed liabilities, other than long-term debt   2082,19271628
Other undisclosed noncurrent liabilities3,3582,4771,910    
Total noncurrent liabilities:3,3952,9852,4412082,5936,150933
Total liabilities:7,7816,0374,9926,3354,2328,6014,688
Stockholders' equity
Stockholders' equity attributable to parent, including:(6,844)(4,210)(1,059)(5,706)(3,893)(8,130)(3,283)
Preferred stock   16161616
Common stock7553244182164
Common stock, value, subscriptions100100100100100100100
Additional paid in capital62,99560,46660,11149,41844,58210,7019,668
Accumulated deficit(69,967)(64,688)(61,216)(55,176)(48,841)(19,135)(13,231)
Other undisclosed stockholders' equity attributable to parent22(94)(60)(67)66 
Stockholders' equity attributable to noncontrolling interest(118)(115)(81)    
Other undisclosed stockholders' equity 23116272   
Total stockholders' equity:(6,961)(4,095)(978)(5,634)(3,893)(8,130)(3,283)
Other undisclosed liabilities and equity (115)(81)(72)   
TOTAL LIABILITIES AND EQUITY:8201,8273,9336283394701,405

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues48123240377657702925
Revenue, net657702925
Cost of revenue(6)(96)(82)(171)(324)(175)(152)
Cost of goods and services sold     (2,750) 
Gross profit:4227159206334526773
Operating expenses(5,558)(7,615)(5,802)(5,003)(3,548)(2,884)(6,043)
Other undisclosed operating income69682171324175152
Operating loss:(5,510)(7,492)(5,561)(4,626)(2,891)(2,182)(5,118)
Nonoperating income (expense)2993,985(487)(1,958)(26,815)(3,722)452
Interest and debt expense(28)(26)(8)1297(60)732
Loss from continuing operations before income taxes:(5,239)(3,533)(6,056)(6,584)(29,409)(5,964)(3,934)
Income tax expense (66)     
Other undisclosed income from continuing operations 3,632     
Net income (loss):(5,239)34(6,056)(6,584)(29,409)(5,964)(3,934)
Net income attributable to noncontrolling interest5,2783,4726,0406,512   
Other undisclosed net income (loss) attributable to parent(5,250)(7,013)(6,032)(6,513)(297)60(732)
Net loss attributable to parent:(5,211)(3,507)(6,048)(6,584)(29,706)(5,904)(4,666)
Preferred stock dividends and other adjustments70      
Net loss available to common stockholders, diluted:(5,141)(3,507)(6,048)(6,584)(29,706)(5,904)(4,666)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):(5,239)34(6,056)(6,584)(29,409)(5,964)(3,934)
Comprehensive income (loss):(5,239)34(6,056)(6,584)(29,409)(5,964)(3,934)
Comprehensive income, net of tax, attributable to noncontrolling interest5,2783,4726,0406,512   
Comprehensive income (loss), net of tax, attributable to parent:403,507(17)(72)(29,409)(5,964)(3,934)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: